NCT00004075View on ClinicalTrials.gov

17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 1999

Primary Completion Date

January 31, 2007

Study Completion Date

January 31, 2007

Conditions
LymphomaUnspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

tanespimycin

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER